Guangjin Pan

Guangzhou Institutes of Biomedicine and Health

Papers

1

Total Citations

2

H-Index

1

About

Guangjin Pan is a leading figure in stem cell biology and regenerative medicine, with a primary focus on somatic cell reprogramming and the generation of induced pluripotent stem cells (iPSCs). His work addresses a critical bottleneck in the field: the inefficiency and heterogeneity of reprogramming, which often leads to unpredictable lineage outcomes. Pan’s major contribution is the development of an innovative robotic-based, spatial-restricting structured flow system that enables the precise selection of monoclonal cell lineages from reprogramming cultures. This technological breakthrough, detailed in his 2024 paper (2 citations), dramatically improves the purity and consistency of iPSC lines, offering a scalable solution for producing high-quality seed cells. By minimizing lineage manipulations, his method enhances the reliability of iPSCs for personalized disease modeling and cell replacement therapies. Though early in citation impact, this work represents a significant step toward clinical translation. Pan’s research bridges engineering and biology, positioning him as a key innovator in advancing regenerative medicine from bench to bedside.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Selecting Monoclonal Cell Lineages from Somatic Reprogramming Using Robotic-Based Spatial-Restricting Structured Flow
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Guangzhou Institutes of Biomedicine and Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago